Note: Ingredients listed on restricted chemical lists
EC/CAS
205-592-6/143-22-6
Name of the chemical
2-(2-(2-butoxyethoxy)ethoxy)ethanol
Concentration
≥1
General Information
Version
1.0
Revision date
2023-02-01
Product name
Ardee XL
REACH No
05571
1.2.1 Relevant identified uses
Professional use Industrial/Professional use spec
Manufacturer Name
Barclay Chemicals Manufacturing Ltd
Emergency telephone
+353 (1) 809 2166
Icons in SDS
Company Information
company name
Barclay Chemicals Manufacturing Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
info@barclay.ie
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice.
2.2 Label elements
Labelling
Precautionary statements
P102 - Keep out of reach of children. P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P280 - Wear protective clothing, eye protection, face protection. P301+P310 - IF SWALLOWED: Immediately call a POISON CENTER or doctor. P302+P352 - IF ON SKIN: Wash with plenty of water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
Supplemental label elements
EUH401 - To avoid risks to human health and the environment, comply with the instructions for use.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %